← All tickers

Is SANA Worth Buying in 2026?

Sana Biotechnology, Inc. Common Stock

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-06-14

Here’s whether Sana Biotechnology, Inc. Common Stock (SANA) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.52% over 10 days); 3-month momentum negative (-18.0%). Currently 59.1% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

SANA is trading below its 200-day MA ($3.84) — a key warning sign the longer-term trend is under pressure. An RSI of 34.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +5.5% compares to +22.9% for SPY (trailed the market by 17.4%). The current 59.1% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $10,551 today
vs. S&P 500 (SPY) — same period trailed market by 17.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($3.84)
✗Above 50-day MA ($3.22)
✓RSI(14) neutral zone (30–70) — currently 34.1
✓Positive return (+5.5%)
!Within 10% of period high (−59.1%)
Period Range $2.68
$2.41 $6.55
RSI (14) 34.1
0 · OversoldOverbought · 100

Key Metrics

Price$2.68
Period Return+5.5%
Period High$6.55
Period Low$2.41
Drawdown−59.1%
MA-50$3.22
MA-200$3.84
RSI (14)34.1
Avg Volume (30d)4.1M
vs. SPYtrailed by 17.4%
Return Rank#649 of 1246

Trade SANA

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers